GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3201 - 3225** of **4050** in total

« First

‹ Prev

…

125

126

127

128

129

130

131

132

133

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgA	Patient 1	22	moderate	G80587NA	486
IgA	Patient 3	11	mild	G72424VO	486
IgA	Patient 4	12	mild	G36544AC	486
IgA	Patient 2	24	mild	G99603GB	487
IgA	Patient 3	11	mild	G78255UI	487
IgM	Patient 3	11	mild	G17266GE	487
IgM	Patient 4	12	mild	G21290RB	487
IgA	Patient 3	4	mild	G86566MF	488
IgA	Patient 4	12	mild	G21675ZL	488
IgM	Patient 2	24	mild	G22768VO	489
IgA	Patient 3	11	mild	G10133VD	489
IgA	Patient 3	4	mild	G30839DN	489
IgA	Patient 3	4	mild	G57449OF	489
IgA	Patient 4	12	mild	G98240FC	489
IgA	Patient 2	15	mild	G11460AB	490
IgA	Patient 3	4	mild	G92022ML	490
IgA	Patient 2	3	mild	G14569AR	491
IgA	Patient 1	22	moderate	G96865DJ	492
IgA	Patient 2	3	mild	G24617OK	492
IgA	Patient 3	11	mild	G71469XA	492
IgM	Patient 1	22	moderate	G75896PD	493
IgA	Patient 2	24	mild	G89993FE	493
IgA	Patient 4	12	mild	G62222PE	493
IgA	Patient 2	24	mild	G58547FH	494
IgA	Patient 3	4	mild	G10789DJ	494